Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Rosario Vidal T"'
Publikováno v:
Revista Chilena de Radiología, Vol 17, Iss 4, Pp 153/195-197 (2011)
Externí odkaz:
https://doaj.org/article/f115785384db40f8b77c95d972efc708
Publikováno v:
Revista Chilena de Radiología, Vol 17, Iss 4, Pp 153/195-197
Externí odkaz:
https://doaj.org/article/39bd08982c7a44ab8228379dd61d93d1
Autor:
Eduardo Terán Brage, Marta Fonseca Santos, Rebeca Lozano Mejorada, Rocío García Domínguez, Alejandro Olivares Hernández, Arantzazu Amores Martín, Rosario Vidal Tocino, Emilio Fonseca Sánchez
Publikováno v:
Case Reports in Oncology, Vol 15, Iss 2, Pp 507-514 (2022)
Autoimmune haemolytic anaemia (AIHA) is an acquired disorder in which antibodies are produced against self-erythrocyte antigens. We distinguish those produced by cold antibodies (IgM), which may be associated with lymphoproliferative syndromes, infec
Externí odkaz:
https://doaj.org/article/c814e45ec3b2410d88ee9078642e6c9c
Autor:
Eduardo Terán Brage, Manuel Heras Benito, Marta Belén Navalón Jiménez, Rosario Vidal Tocino, Edel del Barco Morillo, Emilio Fonseca Sánchez
Publikováno v:
Case Reports in Oncology, Vol 15, Iss 1, Pp 91-98 (2022)
Altered natremia is a common electrolyte disorder in clinical practice and a paraneoplastic manifestation. The syndrome of inappropriate antidiuretic hormone secretion is the first diagnostic suspicion in a patient with cancer and hyponatremia, altho
Externí odkaz:
https://doaj.org/article/35bbf470164f4333aa4b46c8c7b219fe
Autor:
Paula Jimenez-Fonseca, Victoria Foy, Sophie Raby, Alberto Carmona-Bayonas, Lola Macía-Rivas, Virginia Arrazubi, Diego Cacho Lavin, Raquel Hernandez San Gil, Ana Custodio, Juana María Cano, Ana Fernández Montes, Oriol Mirallas, Ismael Macias Declara, Rosario Vidal Tocino, Laura Visa, María Luisa Limón, Paola Pimentel, Nieves Martínez Lago, Tamara Sauri, Marta Martín Richard, Monserrat Mangas, Mireia Gil Raga, Aitana Calvo, Pablo Reguera, Mónica Granja, Alfonso Martín Carnicero, Carolina Hernández Pérez, Paula Cerdá, Lucía Gomez Gonzalez, Francisco Garcia Navalon, Vilma Pacheco Barcia, David Gutierrez Abad, Maribel Ruiz Martín, Jamie Weaver, Wasat Mansoor, Javier Gallego
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background: Trastuzumab and chemotherapy is the standard first-line treatment in human epidermal growth factor receptor 2 (HER2)-positive advanced gastro-oesophageal cancer. The objective was to develop a predictive model for overall survival (OS) an
Externí odkaz:
https://doaj.org/article/cf85aa4387664f46bdb19d331cc85d54
Publikováno v:
Revista chilena de radiología v.17 n.4 2011
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Mujer de 42 anos, que acude a consulta de cirugia, remitida por el servicio de ginecologia, por presentar masa intraabdominal en hipogastrio y fosa iliaca derecha de unos tres anos de evolucion.La exploracion fisica puso de manifiesto un abdomen blan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f80c8c54762f5ac9bbf8aa2b155f360a
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-93082011000400002
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-93082011000400002
Autor:
Eduardo Terán Brage, Jonnathan Roldán Ruíz, Juan Diego Oviedo Rodríguez, Rosario Vidal Tocino, Sara Rodríguez Diego, Pedro Luis Sánchez Hernández, Lorena Bellido Hernández, Emilio Fonseca Sánchez
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 6, Iss , Pp 100153- (2022)
Introduction COVID-19 disease has caused a global health and economic crisis. The introduction of the different COVID-19 vaccines has resulted in a significant decrease in the morbidity and mortality associated with this disease. Adverse effects have
Externí odkaz:
https://doaj.org/article/357e4ff4aa99446683f8e41774ed343a
Autor:
Núria Malats, Sabela Carballal, María Pellisé, Francesc Balaguer, Victor Moreno, Javier Rodriguez, Teresa Ocaña, José Perea, Cristina Santos, Eloy Espin, Miriam Cuatrecasas, Damian Garcia-Olmo, Antonino Spinelli, Lorena Moreno, Lucía Inglada-Pérez, Rogelio González-Sarmiento, Miguel Urioste, Enrique Pastor, Julián Pérez-Pérez, Jesus Fernandez, Alejandro Forero, Marc Marti, Sergio Hernandez-Villafranca, Pilar Orihuela, Rosario Vidal Tocino, Jose Antonio Alcazar, Alfredo Vivas, Cristina Narvaez, Isabel Prieto, Luis Asensio, Irene López Rojo, Sara Encinas Garcia, Elena Hurtado, Luis M Jiménez, Fernando Jiménez, Adriana Cavero, Edurne Alvaro, Maria Luisa Fuenmayor, Marta Jiménez Toscano, Mar Iglesias Comas, Maria Daca, Araceli Ballestero, Javier Die Trill, Gonzalo Sanz, Rodrigo Sanz López, Sirio Melone, Jose A Rueda, Lorena Brandariz, Ignacio Valverde, Jorge Arredondo, Carlos Pastor, Andreana N Holowatyj, Mercedes Martínez Villacampa, Jose Carlos Ruffinelli, José A Sueda Orgaz, Víctor Castellano Megías, Susana Olmedillas-López, Vicente Portugal, María Arriba Domenech, Isabel Peligros Gómez, Cristina Rey Valcárcel, Jaime Zorrilla Ortúzar, Ariadna Sánchez, Ana Ramírez de Molina, Gonzalo Colmenarejo, Isabel Espinosa-Salinas, Lara Fernández, Marta Gómez de Cedrón, Luis Corchete, Juan L García, Paula García Vallés, Ana B Hernández, Abel J Martel, Jéssica Pérez, Ana Burdaspal, Inés Rubio, Amaya Villafañe, Oscar Alonso, Sara Encinas, Ana Teijo, Jorge Baixauli Fons, Lucia Ceniceros Paredes, Carlos Sánchez Justicia, Jana Dziakova, Sara Picazo Marín, María Suárez Solís, Jacinto García, Lidia Estudillo, Franco Marinello, Miquel Kraft, Stefania Landolfi, Inmaculada Salces, Sandra Tapial
Publikováno v:
BMJ Open, Vol 11, Iss 12 (2021)
Purpose The Spanish Early-onset Colorectal Cancer (SECOC) study is a multicentre prospective cohort established in Spain to investigate the molecular basis of early-onset colorectal cancer (EOCRC), including metabolic alterations.Participants 220 pat
Externí odkaz:
https://doaj.org/article/b439e16bbe7f4bafb72b2bd7c2c9a251
Autor:
Paula Jimenez-Fonseca, Alberto Carmona-Bayonas, Alba Martinez-Torron, Maria Alsina, Ana Custodio, Olbia Serra, Diego Cacho Lavin, María Luisa Limón, Tamara Sauri, Flora López, Laura Visa, Mónica Granja, Nieves Martínez Lago, Virginia Arrazubi, Rosario Vidal Tocino, Raquel Hernandez, Gema Aguado, Juana María Cano, Alfonso Martín Carnicero, Monserrat Mangas, Paola Pimentel, Ana Fernández Montes, Ismael Macias Declara, Federico Longo, Avinash Ramchandani, Marta Martín Richard, Alicia Hurtado, Aitor Azkarate, Carolina Hernández Pérez, Raquel Serrano, Javier Gallego
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: Trastuzumab combined with cisplatin and fluoropyrimidines, either capecitabine or 5-fluorouracile (XP/FP), is the standard first-line treatment for advanced, HER2-positive, gastric cancer patients based on the ToGA trial. Despite the lack
Externí odkaz:
https://doaj.org/article/461c7ab35c804b44a5bffb5634234fe5
Autor:
Almudena Cotes Sanchís, Javier Gallego, Raquel Hernandez, Virginia Arrazubi, Ana Custodio, Juana María Cano, Gema Aguado, Ismael Macias, Carlos Lopez, Flora López, Laura Visa, Marcelo Garrido, Nieves Martínez Lago, Ana Fernández Montes, María Luisa Limón, Aitor Azkárate, Paola Pimentel, Pablo Reguera, Avinash Ramchandani, Juan Diego Cacho, Alfonso Martín Carnicero, Mónica Granja, Marta Martín Richard, Carolina Hernández Pérez, Alicia Hurtado, Olbia Serra, Elvira Buxo, Rosario Vidal Tocino, Paula Jimenez-Fonseca, Alberto Carmona-Bayonas
Publikováno v:
PLoS ONE, Vol 15, Iss 7, p e0235848 (2020)
BackgroundSecond-line treatments boost overall survival in advanced gastric cancer (AGC). However, there is a paucity of information as to patterns of use and the results achieved in actual clinical practice.Materials and methodsThe study population
Externí odkaz:
https://doaj.org/article/231893986f554dffb2d589137b70a2f6